A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: Nucleotide excision repair (NER) as potential chemoresistance marker

Masahiro Hirakawa, Yasushi Sato*, Hiroyuki Ohnuma, Tetsuji Takayama, Tamotsu Sagawa, Takayuki Nobuoka, Keisuke Harada, Hiroshi Miyamoto, Yasuhiro Sato*, Yasuo Takahashi, Shinich Katsuki, Michiaki Hirayama, Minoru Takahashi, Michihiro Ono, Masahiro Maeda, Kohichi Takada, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Rishu TakimotoMasayoshi Kobune, Koichi Hirata, Junji Kato

*この論文の責任著者

研究成果: ジャーナルへの寄稿学術論文査読

63 被引用数 (Scopus)

フィンガープリント

「A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: Nucleotide excision repair (NER) as potential chemoresistance marker」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science